AI-assisted judgment glaucoma was approved, and Tencent became the first Internet technology enterprise in China to be approved for innovative medical devices

Recently, after review, the State Drug Administration approved the application for the registration of

In order to encourage medical device innovation and stimulate the high-quality development of the industry, in 2018, the State Food and Drug Administration revised and issued the "Special Examination Procedure for Innovative Medical Devices", which set up a special approval channel

Relying on the joint scientific research results of Tencent Miying and the team of Professor Wang Ningli of Beijing Tongren Hospital, this set of products uses the artificial intelligence algorithm of deep learning to provide clinically assisted triage suggestions

Tencent Miying provides doctors with auxiliary advice on the diagnosis of glaucoma

In addition, this innovative medical device product also provides a quality control method for fundus camera imaging, which can automatically identify common fundus image quality problems in clinical practice, such as non-fundus images, large-area fouling and refractive interstitial turbidity, effectively improving the accuracy and confidence of auxiliary diagnosis, and is expected to solve the problem

Glaucoma is the second most blinding eye disease in the world, second only to cataracts, compared to cataracts that can be surgically restored, the vision loss caused by glaucoma is irreversible, and only early screening, early diagnosis, and early treatment can avoid blindness

Professor Wang Ningli of Beijing Tongren Hospital pointed out that the distribution of medical resources in China is uneven, and it is difficult to efficiently make glaucoma screening cover all populations, so the detection rate is low and the late rate is high

Qian Tianyi, general manager of Tencent Miying, introduced that Tencent Miying's "chronic glaucoma-like optic neuropathy fundus image-assisted diagnosis software" has the ability to judge lesion risk and fundus image quality control, which can not only assist clinicians to improve the efficiency and accuracy of diagnosing glaucoma, but also with the help of cloud computing, 5G network and other digital technologies, it is expected to rely on the Internet to form a new model of remote screening and expand the coverage

In addition to winning the medical AI "three types of certificates" in AI-assisted glaucoma diagnosis, Tencent Miying has also successfully obtained the medical AI "three-class certificate" for AI-assisted pneumonia diagnosis, and won the medical AI "three-class certificate" with the highest threshold in different specialty fields, which confirms the AI technology strength and product research and development capabilities stored by Tencent Miying, which can meet the professional and diversified needs of innovative medical devices